The interaction between sialic acids and Siglec-5/14 hindered the CD11b/CD18-regulated binding between neutrophils and antibody-opsonized tumor cells, representing a target for innate checkpoint blockage in the tumor microenvironment [272]. Here, ITGB2 is linked to neoplasm.